» Articles » PMID: 17873339

Role of Advanced Glycation End Products in Hypertension and Atherosclerosis: Therapeutic Implications

Overview
Date 2007 Sep 18
PMID 17873339
Citations 29
Authors
Affiliations
Soon will be listed here.
Abstract

The vascular diseases, hypertension and atherosclerosis, affect millions of individuals worldwide, and account for a large number of deaths globally. A better understanding of the mechanism of these conditions will lead to more specific and effective therapies. Hypertension and atherosclerosis are both characterized by insulin resistance, and we suggest that this plays a major role in their etiology. The cause of insulin resistance is not known, but may be a result of a combination of genetic and lifestyle factors. In insulin resistance, alterations in glucose and lipid metabolism lead to the production of excess aldehydes including glyoxal and methylglyoxal. These aldehydes react non-enzymatically with free amino and sulfhydryl groups of amino acids of proteins to form stable conjugates called advanced glycation end products (AGEs). AGEs act directly, as well as via receptors to alter the function of many intra- and extracellular proteins including antioxidant and metabolic enzymes, calcium channels, lipoproteins, and transcriptional and structural proteins. This results in endothelial dysfunction, inflammation and oxidative stress. All these changes are characteristic of hypertension and atherosclerosis. Human and animal studies have demonstrated that increased AGEs are also associated with these conditions. A pathological role for AGEs is substantiated by studies showing that therapies that attenuate insulin resistance and/or lower AGEs, are effective in decreasing oxidative stress, lowering blood pressure, and attenuating atherosclerotic vascular changes. These interventions include lipoic acid and other antioxidants, AGE breakers or soluble receptors of AGEs, and aldehyde-binding agents like cysteine. Such therapies may offer alternative specific means to treat hypertension and atherosclerosis. An adjunct therapy may be to implement lifestyle changes such as weight reduction, regular exercise, smoking cessation, and increasing dietary intake of fruits and vegetables that also decrease insulin resistance as well as oxidative stress.

Citing Articles

Hemodynamic parameters and diabetes mellitus in community-dwelling middle-aged adults and elders: a community-based study.

Wu T, Wu Y, Chou C, Cheng C, Lu S, Wang L Sci Rep. 2024; 14(1):12032.

PMID: 38797773 PMC: 11128448. DOI: 10.1038/s41598-024-62866-7.


Joint Association of Dietary Protein Intake and Eating Habits with the Risk of Gestational Diabetes Mellitus: A Case-Control Study.

Gong K, Xie L, Cao Y, Yu X, Qiang W, Fan T Nutrients. 2023; 15(20).

PMID: 37892408 PMC: 10610363. DOI: 10.3390/nu15204332.


Insulin Resistance and Hypertension: Mechanisms Involved and Modifying Factors for Effective Glucose Control.

Sakr H, Sirasanagandla S, Das S, Bima A, Elsamanoudy A Biomedicines. 2023; 11(8).

PMID: 37626767 PMC: 10452601. DOI: 10.3390/biomedicines11082271.


Beneficial Effect of Cuban Policosanol on Blood Pressure and Serum Lipoproteins Accompanied with Lowered Glycated Hemoglobin and Enhanced High-Density Lipoprotein Functionalities in a Randomized, Placebo-Controlled, and Double-Blinded Trial with....

Cho K, Nam H, Baek S, Kang D, Na H, Komatsu T Int J Mol Sci. 2023; 24(6).

PMID: 36982259 PMC: 10048825. DOI: 10.3390/ijms24065185.


Associations of genetic markers of diabetes mellitus with carotid atherosclerosis: a community-based case-control study.

Wu T, Chou C, Cheng C, Lu S, Wu Y, Wang L Cardiovasc Diabetol. 2023; 22(1):51.

PMID: 36894991 PMC: 9999522. DOI: 10.1186/s12933-023-01787-7.